4.010USD-0.74%Mkt Cap: 377.28M USDP/E: —Last update: 2026-05-26
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an ora…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap377.28M USD
Enterprise Value224.58M USD
Revenue (TTM)9.01M USD
Gross Profit29.36M USD
Net Income (TTM)-79.20M USD
Revenue/Share0.1250 USD
Last Price4.010 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees45
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.49
PEG—
EV/EBITDA-2.50
EV/Revenue24.92
P/S42.27
P/B2.26
EPS (TTM)-2.07
EPS (Forward)-0.90
52W Range
1.35076% of range4.830
52W High4.830 USD
52W Low1.350 USD
Profitability
Gross Margin83.60%
Oper. Margin-748.49%
EBITDA Margin0.00%
Profit Margin-225.55%
ROE-42.51%
ROA-27.27%
Growth
Revenue Growth-90.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-85.62M USD
CapEx (TTM)3.00M USD
FCF Margin-612.07%
FCF Yield-14.62%
Net Debt-156.47M USD
Net Debt/EBITDA1.74
Balance Sheet
Debt/Equity0.41
Current Ratio10.18
Quick Ratio9.88
Book Value/Sh1.786 USD
Cash/Share2.478 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 14, 2019
Splits
Last Split1:30
Split DateApr 28, 2025
Analyst Consensus
Rating—
Target (Mean)11.67 USD
Target Range10.00 USD – 13.00 USD
# Analysts3
Ownership
Shares Out.94.32M
Float57.41M
Insiders0.61%
Institutions99.59%
Short Interest
Short Ratio7.9d
Short % Float3.31%
Short % Out.3.31%
Shares Short3.12M
Short (prev mo.)3.12M
Technical
SMA 504.110 (-2.4%)
SMA 2003.668 (+9.3%)
Beta0.32
S&P 52W Chg28.31%
Avg Vol (30d)351.75K
Avg Vol (10d)352.02K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—